STOCK TITAN

Chad Robins lists multiple ADPT share sales in Form 144 (ADPT)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Chad Robins filed a Form 144 notifying proposed sales of Common Stock in multiple transactions. The notice lists several sales on dates in January–March 2026, including a 03/03/2026 entry for 53,083 shares and multiple entries on 03/02/2026 and 02/27/2026.

The filing lists Restricted Stock Units (140,567) and Performance Stock Units (329,600) with an 03/10/2026 date. The Form 144 records individual share sales with dollar amounts per transaction; cash‑flow treatment and any aggregate total are not provided in the excerpt.

Positive

  • None.

Negative

  • None.

Insights

Routine resale notice listing multiple insider sales across early 2026.

The filing is a regulatory notice of proposed dispositions of Common Stock by Chad Robins, showing multiple dated sale entries in January–March 2026 with per‑trade share counts and proceeds. The notice also lists RSUs (140,567) and PSUs (329,600) dated 03/10/2026.

These entries are administrative resale disclosures rather than operational developments; the excerpt does not state aggregate proceeds, whether sales were effected under a trading plan, or cash‑flow recipients. Subsequent filings may clarify method and totals.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Chad Robins' Form 144 for ADPT disclose?

The filing notifies proposed sales of ADPT Common Stock by Chad Robins, listing multiple dated transactions in Jan–Mar 2026. It includes per‑trade share counts (for example, 53,083 shares on 03/03/2026) and dollar amounts for each entry.

Does the Form 144 show total shares being sold by Chad Robins?

The excerpt lists individual sales but does not present an aggregate total. It shows multiple transactions with specific share counts on various dates rather than a single summed amount in the provided text.

Are there any equity awards referenced in the filing for ADPT?

Yes. The filing lists 140,567 Restricted Stock Units and 329,600 Performance Stock Units with a 03/10/2026 date. These award counts appear in the securities section of the excerpt.

Do the Form 144 entries indicate whether sales were under a trading plan?

The provided excerpt does not state that transactions were executed pursuant to a Rule 10b5‑1 or other trading plan. The filing lists dates, share counts, and dollar amounts; no trading‑plan language appears in the text shown.

Where can I find the dollar proceeds for the reported sales?

Each transaction row in the excerpt includes a dollar amount alongside the share count (for example, $823,826.47 for 53,083 shares on 03/03/2026). Review the listed per‑trade entries to see the reported proceeds.
Adaptive Biotechnologies

NASDAQ:ADPT

View ADPT Stock Overview

ADPT Rankings

ADPT Latest News

ADPT Latest SEC Filings

ADPT Stock Data

2.08B
149.25M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
SEATTLE